Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>

Common stock purchase or sale:
Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
2021-11-29 Purchase |
2021-12-01 7:32 pm |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
16,000,000 | $1.25 | $20,000,000 | 78,799,315 (Indirect) |
View |
2021-02-02 Purchase |
2021-02-02 5:32 pm |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
8,360,000 | $1 | $8,360,000 | 32,427,067 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
2025-01-17 Exercise(A) |
2025-03-12 8:56 pm |
N/A N/A |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
3,458,571 | $2.51 | 9,266,645 (Indirect) |
View |
2025-01-17 Exercise |
2025-01-22 4:11 pm |
2024-03-18 2029-03-18 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
3,458,571 | $0 | 10,375,713 (Indirect) |
View |
2025-01-17 Option Award |
2025-01-22 4:11 pm |
2024-03-18 2029-03-18 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
10,375,713 | $0 | 10,375,713 (Indirect) |
View |
2024-03-18 Option Award |
2024-03-20 5:20 pm |
2024-03-18 2029-03-18 |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
5,764,285 | $0 | 9,266,645 (Indirect) |
View |
2022-12-28 Option Award |
2022-12-29 5:01 pm |
N/A N/A |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
14,230,418 | $0.8784 | 70,047,204 (Indirect) |
View |
2022-04-21 Other(A) |
2022-07-07 5:27 pm |
N/A N/A |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
27,982,529 | $0 | 83,799,315 (Indirect) |
View |
2022-02-01 Other |
2022-02-01 5:05 pm |
N/A N/A |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
2,500,000 | $1.25 | 58,316,786 (Indirect) |
View |
2021-02-10 Option Award |
2021-02-11 5:46 pm |
N/A N/A |
Outlook Therapeutics Inc. | OTLK | Sukhtian Ghiath M. GMS Ventures & Investments Director 10% Owner |
1,013,627 | $1 | 62,799,315 (Indirect) |
View |